login
MEMBERSHIP
     - OVERVIEW
     - PHARMACY OWNERS
     - PHARMACISTS
     - CORPORATE PARTNERS
partners


Novartis in the UK

At Novartis, healthcare forms the core of our business. Our name, derived from the Latin novae artes, meaning "new skills", reflects our commitment to focus on research and development, bringing innovative new products to our customers.

In the UK, Novartis employs around 3,000 people at eleven sites across the UK. Our sites are spread around the country: Frimley (pharmaceuticals and HQ), Horsham (R&D, consumer health and manufacturing), Grimsby (manufacturing), London (research and a charitable foundation), Dundee, Litlington and Braintree (animal health), Southampton and Farnham (eye care), Bordon (generics) and Alfreton (manufacturing).

We are proud that Novartis’ products reach patients in the NHS everyday, actively reducing morbidity and mortality and making an important contribution to improving the health of the nation. We aspire to be a responsible and conscientious global citizen with values based on trust, transparency and accountability.
We want to provide affordable, and thus accessible, well established treatment options to the best of our abilities and as far as our resources permit, for as many people as possible.

Key facts and figures:
  • Novartis was formed from the merger of Swiss companies Ciba Geigy and Sandoz
  • Worldwide, Novartis employs more than 78,000 people (3,000 in the UK)
  • We spend around £1 million per day on research and development in the UK
  • Novartis has been named by Fortune magazine as one of the 10 Best Companies to Work For in Europe and by the Financial Times as one of the Best Places To Work in the UK
  • Novartis constantly strives towards being a responsible corporate citizen.
Our projects include:
  • Making our anti-malarial drug available at cost to developing nations under a unique public-private partnership with the WHO
  • Donating half a million free tuberculosis treatments through WHO
  • Committing to providing free medicine for all leprosy patients.